November 27, 2023 • 8:00 AM EST ASP Isotopes Inc. Enters Into Memorandum of Understanding (MOU) With Second US-based Small Modular Reactor (SMR) Company To Supply High Assay Low Enriched Uranium (HALEU)
October 29, 2023 • 7:35 PM EDT ASP Isotopes Inc. Enters Strategic Relationship With PET Labs Pharmaceuticals for the Distribution of Medical Isotopes
October 27, 2023 • 8:00 AM EDT ASP Isotopes Announces Closing of $9.1 Million Private Placement of Common Stock
October 19, 2023 • 8:00 AM EDT Professor Mike Gorley From UK Atomic Energy Authority to Join Board of Directors of ASP Isotopes Inc.
October 9, 2023 • 8:20 AM EDT ASP Isotopes Announces Private Placement of Approximately $8 Million Shares of Common Stock, Priced “At the Market” Under NASDAQ Rules
September 28, 2023 • 8:00 AM EDT ASP Isotopes Inc. Enters Into Memorandum of Understanding With a Small Modular Reactor Company To Supply High Assay Low Enriched Uranium (HALEU)
June 27, 2023 • 8:30 AM EDT ASP Isotopes Inc. Secures $9 Million Supply Contract with US Customer for Highly Enriched Isotopes
May 8, 2023 • 9:29 AM EDT ASP Isotopes Inc. Enters into Multi-Year Supply Agreement for Highly Enriched Carbon-14
